Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.36.26EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.531EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.531EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.531ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.531ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.531EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.531EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.531ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.531ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.45EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.45ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.45ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.45EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.45EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.200EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.200EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.200ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.200ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.200EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.200EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.200ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.200ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.35EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.35ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.35ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.35EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.35EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.178EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.178EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.178ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.178ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.178EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.178EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.178ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.178ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.208EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.208EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.208ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.208ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.208EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.208EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used